Target intelligence / Profile preview

Solute carrier family 22 member 8 (OAT3)

Target
OAT3
Molecular classification
Transporter, Solute carrier family
01

Overview

Solute carrier family 22 member 8 (OAT3) is an organic anion transporter protein encoded by the human SLC22A8 gene. OAT3 is a membrane protein predominantly localized to the basolateral membrane of renal proximal tubule cells. It mediates the uptake and excretion of a broad range of endogenous metabolites and xenobiotic organic anions—including numerous drugs such as penicillin G, methotrexate, indomethacin, and ciprofloxacin—by functioning as an antiporter that exchanges incoming organic anions for intracellular dicarboxylates like α-ketoglutarate. OAT3 activity plays a crucial role in renal drug elimination and the clearance of potentially toxic metabolites. Genetic variants of OAT3 can influence the transporter’s substrate specificity and activity, contributing to interindividual differences in drug pharmacokinetics and risk of drug toxicity. OAT3 also participates in the transport of plant-derived metabolites and uremic toxins and is implicated in the pathogenesis of certain renal diseases such as Balkan nephropathy.

Other names
Organic anion transporter 3SLC22A8OAT-3
02

Mechanism of action

Drugs are eliminated primarily via active transport (anion exchange with dicarboxylates, e.g. α-ketoglutarate) across renal proximal tubule cells, mediated by antiport exchange

03

Biological functions

Renal excretion of endogenous and exogenous organic anionsDrug eliminationCellular detoxificationOrganic ion transport
04

Disease associations

Renal diseaseDrug-induced nephrotoxicityHypertensionBalkan nephropathy
05

Safety considerations

Renal impairment can alter substrate drug clearance, causing toxicity or therapeutic failureOAT3 inhibition or genetic loss-of-function can significantly affect pharmacokinetics of interacting drugs
06

Interacting drugs

Penicillin G (benzylpenicillin)

7 more in the full profile.

07

Biomarkers

Genetic variants of SLC22A8 (OAT3) may serve as biomarkers for variations in renal drug clearance

Beyond the preview

Go deeper on Solute carrier family 22 member 8 (OAT3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 22 member 8 (OAT3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call